PAPLN
Papilin
Also known as: MGC50452, PPN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95428
- Gene
- PAPLN
- Ensembl
- ENSG00000100767
- Chromosome
- 14
- Canonical length
- 1278 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in extracellular matrix organization and nervous system development. Predicted to be located in basement membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1278 residues, UniProt reviewed canonical sequence.
>O95428|PAPLN
1 MRLLLLVPLL LAPAPGSSAP KVRRQSDTWG PWSQWSPCSR TCGGGVSFRE RPCYSQRRDG
61 GSSCVGPARS HRSCRTESCP DGARDFRAEQ CAEFDGAEFQ GRRYRWLPYY SAPNKCELNC
121 IPKGENFYYK HREAVVDGTP CEPGKRDVCV DGSCRVVGCD HELDSSKQED KCLRCGGDGT
181 TCYPVAGTFD ANDLSRGYNQ ILIVPMGATS ILIDEAAASR NFLAVKNVRG EYYLNGHWTI
241 EAARALPAAS TILHYERGAE GDLAPERLHA RGPTSEPLVI ELISQEPNPG VHYEYHLPLR
301 RPSPGFSWSH GSWSDCSAEC GGGHQSRLVF CTIDHEAYPD HMCQRQPRPA DRRSCNLHPC
361 PETKRWKAGP WAPCSASCGG GSQSRSVYCI SSDGAGIQEA VEEAECAGLP GKPPAIQACN
421 LQRCAAWSPE PWGECSVSCG VGVRKRSVTC RGERGSLLHT AACSLEDRPP LTEPCVHEDC
481 PLLSDQAWHV GTWGLCSKSC SSGTRRRQVI CAIGPPSHCG SLQHSKPVDV EPCNTQPCHL
541 PQEVPSMQDV HTPASNPWMP LGPQESPASD SRGQWWAAQE HPSARGDHRG ERGDPRGDQG
601 THLSALGPAP SLQQPPYQQP LRSGSGPHDC RHSPHGCCPD GHTASLGPQW QGCPGAPCQQ
661 SRYGCCPDRV SVAEGPHHAG CTKSYGGDST GGMPRSRAVA STVHNTHQPQ AQQNEPSECR
721 GSQFGCCYDN VATAAGPLGE GCVGQPSHAY PVRCLLPSAH GSCADWAARW YFVASVGQCN
781 RFWYGGCHGN ANNFASEQEC MSSCQGSLHG PRRPQPGASG RSTHTDGGGS SPAGEQEPSQ
841 HRTGAAVQRK PWPSGGLWRQ DQQPGPGEAP HTQAFGEWPW GQELGSRAPG LGGDAGSPAP
901 PFHSSSYRIS LAGVEPSLVQ AALGQLVRLS CSDDTAPESQ AAWQKDGQPI SSDRHRLQFD
961 GSLIIHPLQA EDAGTYSCGS TRPGRDSQKI QLRIIGGDMA VLSEAELSRF PQPRDPAQDF
1021 GQAGAAGPLG AIPSSHPQPA NRLRLDQNQP RVVDASPGQR IRMTCRAEGF PPPAIEWQRD
1081 GQPVSSPRHQ LQPDGSLVIS RVAVEDGGFY TCVAFNGQDR DQRWVQLRVL GELTISGLPP
1141 TVTVPEGDTA RLLCVVAGES VNIRWSRNGL PVQADGHRVH QSPDGTLLIY NLRARDEGSY
1201 TCSAYQGSQA VSRSTEVKVV SPAPTAQPRD PGRDCVDQPE LANCDLILQA QLCGNEYYSS
1261 FCCASCSRFQ PHAQPIWQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAPLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- kidney: 41 nTPM
- spleen: 28 nTPM
- cervix: 25 nTPM
- thyroid gland: 23 nTPM
- fallopian tube: 20 nTPM
- endometrium: 19 nTPM
Single-cell type
- proximal tubule cells: 224 nCPM
- astrocytes: 168 nCPM
- peritubular myoid cells: 120 nCPM
- pituicytes/fscs: 118 nCPM
- müller glia: 94 nCPM
- leydig cells: 87 nCPM
Immune cell
- plasmacytoid DC: 5.5 nTPM
- neutrophil: 2.5 nTPM
- basophil: 0.7 nTPM
- classical monocyte: 0.5 nTPM
- naive B-cell: 0.5 nTPM
- memory B-cell: 0.4 nTPM
Brain region
- basal ganglia: 20 nTPM
- choroid plexus: 17 nTPM
- amygdala: 17 nTPM
- cerebral cortex: 16 nTPM
- midbrain: 15 nTPM
- hippocampal formation: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Pancreatic trypsin inhibitor Kunitz domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- ADAMTS/ADAMTS-like, Spacer 1
- PLAC
- Immunoglobulin I-set
- Immunoglobulin V-set domain
- ADAMTS/ADAMTS-like
- Immunoglobulin-like fold
- Proteinase inhibitor I2, Kunitz, conserved site
- Immunoglobulin-like domain superfamily
- Thrombospondin type-1 repeat superfamily
- Pancreatic trypsin inhibitor Kunitz domain superfamily
- ADAMTS/ADAMTS-like, cysteine-rich domain 3
- ADAMTS and ADAMTS-like
- Kunitz/Bovine pancreatic trypsin inhibitor domain
- Thrombospondin type 1 domain
- ADAM-TS Spacer 1
- Immunoglobulin I-set domain
- PLAC (protease and lacunin) domain
- Immunoglobulin domain
- Thrombospondin type 1 domain
- ADAMTS cysteine-rich domain
- Linking region between Kunitz_BPTI and I-set on papilin
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAPLN as an antibody target. Whether an autoantibody or antibody against PAPLN could matter depends on whether native PAPLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAPLN is annotated as secreted, so native PAPLN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PAPLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...